Engineered silica nanoparticles known as C’ dots have demonstrated the ability to kill prostate tumor cells by inducing ferroptosis and reawakening antitumor immunity. Researchers have successfully combined these particles with checkpoint blockade therapy to achieve complete remission in 40% of aggressive cancer models. This platform could transform immunologically cold tumors into hot ones, finally unlocking the potential of immunotherapy for diseases that have historically been resistant to such treatments.
Read the full article at Genetic Engineering News
Want to create content about this topic? Use Nemati AI tools to generate articles, social posts, and more.





